Eustomox IV 400mg Infusion
Marketer
Eustoma Laboratories Pvt Ltd
Salt Composition
Moxifloxacin (400mg)
Overview Eustomox IV 400mg Infusion
Intravenous Eustomox 400mg is a broad-spectrum antibiotic indicated for various bacterial infections. Its applications include treating infections affecting the urinary tract, upper respiratory system (nose and throat), skin, soft tissues, and lungs (pneumonia). The medication's mechanism involves inhibiting the growth of infectious bacteria. Administered intravenously by a medical professional, this injectable formulation is reserved for patients unable to take oral medication, such as those hospitalized or unconscious. Self-administration is strictly prohibited. Complete the prescribed course, even if symptoms improve, avoiding missed doses. Common side effects can include headache, nausea, dizziness, and diarrhea. Injection site reactions, such as pain, swelling, or redness, may also occur. These typically subside spontaneously; however, persistent or severe side effects warrant immediate medical attention. While diarrhea is a possible side effect usually resolving upon treatment completion, persistent diarrhea or blood in the stool requires consultation with a physician. Pre-existing allergies to any component of Eustomox 400mg contraindicate its use. Patients with impaired kidney function require careful monitoring during treatment.
Uses of Eustomox IV 400mg Infusion
Managing bacterial infections of the eye
Major Benefits of Eustomox IV 400mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Eustomox IV 400mg Infusion:
- Injection site reactions (pain, swelling, redness)
- Eye discomfort
- Dry eye
- Burning sensation in eye
How to use Eustomox IV 400mg Infusion:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Eustomox IV 400mg Infusion works:
Eustomox IV, a 400mg intravenous antibiotic, inhibits bacterial DNA-gyrase, a crucial enzyme for bacterial replication and repair. This mechanism of action effectively halts bacterial cell division and leads to bacterial cell death.
SAFETY ADVICE
AlcoholSAFE
Eustomox IV 400mg Infusion does not interact adversely with alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Eustomox IV 400mg Infusion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Administration of Eustomox IV 400mg via infusion is likely unsafe while breastfeeding. Available human data indicate potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Administering Eustomox IV 400mg Infusion could induce adverse reactions impairing driving capabilities. These reactions might include dizziness, lightheadedness, temporary visual disturbances, or brief fainting episodes, all potentially affecting safe operation of a vehicle.
KidneySAFE IF PRESCRIBED
Eustomox IV 400mg infusion poses no known safety concerns for patients with renal impairment; dosage modification isn't necessary. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advised.
LiverCAUTION
Exercise caution when administering 400mg Eustomox IV infusions to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Eustomox IV 400mg infusion use in such patients is limited. Dosage adjustments are not advised for those with mild to moderate liver dysfunction.
What if you forget to take Eustomox IV 400mg Infusion :
Omit Eustomox IV 400mg Infusion doses should prompt immediate physician consultation.
Facts to Know About Eustomox IV 400mg Infusion
| Label | Value |
|---|---|
| Chemical Category | Quinolone antibiotic |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Fluoroquinolones |
3,018 People bought this recently